Beyond the Hype: The 3 Core Medical Device Nearshoring Trends Reshaping US Medtech

For years, “nearshoring” was treated as a buzzword discussed at healthcare logistics conferences. Today, it has hardened into a fundamental structural shift in how US medical technology is built, regulated, and delivered.

As geopolitical tensions and a shifting regulatory environment challenge traditional offshore models, forward-thinking OEMs are anchoring their operations closer to home. Let’s break down the three primary medical device nearshoring trends changing the industry and how you can capitalize on them.

1. Designing for the Outpatient Shift (The ASC Surge)

One of the most consequential trends in US healthcare is the massive migration of clinical procedures from massive, acute-care hospitals to agile Ambulatory Surgery Centers (ASCs). Backed by CMS reimbursement expansions, procedures spanning orthopedics, general surgery, and cardiovascular therapy are rapidly moving outpatient.

This has completely changed what needs to be manufactured:

• ASCs require a smaller device footprint, strict per-procedure cost efficiencies, and rapid turnarounds on specialized consumables.

• Nearshore contract manufacturers are adapting faster than rigid overseas factories, letting OEMs re-engineer their product lines to fit the highly sensitive, margin-focused demands of the ASC channel.

2. Balancing the US-Mexico Manufacturing Equation

When medtech leaders look to nearshore, the choice frequently narrows down to a strategic cross-border synergy between the US and Mexico. Rather than choosing one over the other, the most successful operations are utilizing a blended model:

This geographic flexibility means a device can be ideated in California or Minnesota, scaled and assembled across the border, and trucked to a US hospital system in days—bypassing unpredictable ocean freight completely.

3. Product Cybersecurity Built from Day One

The rise of connected care platforms, wearable diagnostics, and AI-driven surgical tools means modern medical devices are as much software as they are hardware. Consequently, product cybersecurity has become an absolute priority for regulators.

Overseas manufacturing introduces deep IP (Intellectual Property) risks and potential code vulnerabilities that can complicate FDA approval. Keeping your manufacturing partner within North America simplifies the enforcement of strict data security compliance, allowing firmware flashing and connectivity testing to happen inside an ironclad, legally protected region.

Is Your Supply Chain Ready?

The macroeconomic data shows that medical manufacturing continues to maintain strong performance, but the margin for error has shrunk. If your supply chain relies on a single point of failure thousands of miles away, the time to diversify is now. Partnering with a North American medical device manufacturer doesn’t just mitigate your current trade risk—it positions your product line to be faster, safer, and more adaptive to the needs of modern US healthcare.